Shanghai First Pharmacy’s New Chief Accelerates Balian Reorganization
This article was originally published in PharmAsia News
Shanghai First Pharmacy Co., Shanghai's top drug retailer, has appointed industry veteran Zhen-Wu Xu its new CEO. Hailing from Bailian Group, Wu is expected to accelerate the reorganization of Bailian's two subsidiaries, SFP and Huifeng Pharmaceutics. According to a company official, both subsidiaries have completed the integration of their marketing channels and management. The consolidation of wholesale and chain store retail business, as well as sales and distribution, will follow. SFP plans to set up a chain of drugstores in shopping centers and supermarkets by tapping on Huifeng Pharmaceutics' rich experience in drug chain store management. (Click here for more)
You may also be interested in...
Amgen and Mylan will face US Food and Drug Administration actions dates on two of their biosimilar candidates in December, while ANDA sponsors have date-certain launches for two generic products.
With the European Commission "carefully assessing" the judgment of Europe's highest court that CBD is not a narcotic, HBW Insight speaks to an expert in cannabis law about what is likely to happen next.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.